申请人:Prosetta Antiviral, Inc.
公开号:US20190111044A1
公开(公告)日:2019-04-18
This invention provides, among other things, tetrahydroisoquinolines useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus, such as HIV, or treating a disease, such as AIDS.